MENU
Aim higher

LeukeMab

Design of an anti-CD160 mAb targeting CLL, HCL and immune cells for leukemia immunotherapy

Start date: 
01-03-2017
Project Duration: 
0months
Technological Area: 
Cytology, Cancerology, Oncology
Market Area: 
Drug delivery and other equipment (including kidney dialysis machines)